232 related articles for article (PubMed ID: 22754485)
1. Using physiologically-based pharmacokinetic models to incorporate chemical and non-chemical stressors into cumulative risk assessment: a case study of pesticide exposures.
Wason SC; Smith TJ; Perry MJ; Levy JI
Int J Environ Res Public Health; 2012 May; 9(5):1971-83. PubMed ID: 22754485
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P450-specific human PBPK/PD models for the organophosphorus pesticides: chlorpyrifos and parathion.
Foxenberg RJ; Ellison CA; Knaak JB; Ma C; Olson JR
Toxicology; 2011 Jul; 285(1-2):57-66. PubMed ID: 21514354
[TBL] [Abstract][Full Text] [Related]
3. Development of a source-to-outcome model for dietary exposures to insecticide residues: an example using chlorpyrifos.
Hinderliter PM; Price PS; Bartels MJ; Timchalk C; Poet TS
Regul Toxicol Pharmacol; 2011 Oct; 61(1):82-92. PubMed ID: 21722690
[TBL] [Abstract][Full Text] [Related]
4. Development of a physiologically based pharmacokinetic and pharmacodynamic model to determine dosimetry and cholinesterase inhibition for a binary mixture of chlorpyrifos and diazinon in the rat.
Timchalk C; Poet TS
Neurotoxicology; 2008 May; 29(3):428-43. PubMed ID: 18394709
[TBL] [Abstract][Full Text] [Related]
5. A Physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model for the organophosphate insecticide chlorpyrifos in rats and humans.
Timchalk C; Nolan RJ; Mendrala AL; Dittenber DA; Brzak KA; Mattsson JL
Toxicol Sci; 2002 Mar; 66(1):34-53. PubMed ID: 11861971
[TBL] [Abstract][Full Text] [Related]
6. A Novel Method for the Development of Environmental Public Health Indicators and Benchmark Dose Estimation Using a Health-Based End Point for Chlorpyrifos.
Zurlinden TJ; Reisfeld B
Environ Health Perspect; 2018 Apr; 126(4):047009. PubMed ID: 29681141
[TBL] [Abstract][Full Text] [Related]
7. An age-dependent physiologically based pharmacokinetic/pharmacodynamic model for the organophosphorus insecticide chlorpyrifos in the preweanling rat.
Timchalk C; Kousba AA; Poet TS
Toxicol Sci; 2007 Aug; 98(2):348-65. PubMed ID: 17504771
[TBL] [Abstract][Full Text] [Related]
8. The implications of using a physiologically based pharmacokinetic (PBPK) model for pesticide risk assessment.
Lu C; Holbrook CM; Andres LM
Environ Health Perspect; 2010 Jan; 118(1):125-30. PubMed ID: 20056589
[TBL] [Abstract][Full Text] [Related]
9. Appraisal of risks from nonoccupational exposure to chlorpyrifos.
Cochran RC
Regul Toxicol Pharmacol; 2002 Feb; 35(1):105-21. PubMed ID: 11846640
[TBL] [Abstract][Full Text] [Related]
10. Modeling exposures to organophosphates and pyrethroids for children living in an urban low-income environment.
Wason SC; Julien R; Perry MJ; Smith TJ; Levy JI
Environ Res; 2013 Jul; 124():13-22. PubMed ID: 23664738
[TBL] [Abstract][Full Text] [Related]
11. Binary combinations of organophosphorus and synthetic pyrethroids are more potent acetylcholinesterase inhibitors than organophosphorus and carbamate mixtures: An in vitro assessment.
Arora S; Balotra S; Pandey G; Kumar A
Toxicol Lett; 2017 Feb; 268():8-16. PubMed ID: 27988393
[TBL] [Abstract][Full Text] [Related]
12. Cholinesterase inhibition in chlorpyrifos workers: Characterization of biomarkers of exposure and response in relation to urinary TCPy.
Garabrant DH; Aylward LL; Berent S; Chen Q; Timchalk C; Burns CJ; Hays SM; Albers JW
J Expo Sci Environ Epidemiol; 2009 Nov; 19(7):634-42. PubMed ID: 18716607
[TBL] [Abstract][Full Text] [Related]
13. Parameters for pyrethroid insecticide QSAR and PBPK/PD models for human risk assessment.
Knaak JB; Dary CC; Zhang X; Gerlach RW; Tornero-Velez R; Chang DT; Goldsmith R; Blancato JN
Rev Environ Contam Toxicol; 2012; 219():1-114. PubMed ID: 22610175
[TBL] [Abstract][Full Text] [Related]
14. Use of a probabilistic PBPK/PD model to calculate Data Derived Extrapolation Factors for chlorpyrifos.
Poet TS; Timchalk C; Bartels MJ; Smith JN; McDougal R; Juberg DR; Price PS
Regul Toxicol Pharmacol; 2017 Jun; 86():59-73. PubMed ID: 28238854
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and pharmacodynamics of chlorpyrifos in adult male Long-Evans rats following repeated subcutaneous exposure to chlorpyrifos.
Ellison CA; Smith JN; Lein PJ; Olson JR
Toxicology; 2011 Sep; 287(1-3):137-44. PubMed ID: 21708215
[TBL] [Abstract][Full Text] [Related]
16. Application of a source-to-outcome model for the assessment of health impacts from dietary exposures to insecticide residues.
Price PS; Schnelle KD; Cleveland CB; Bartels MJ; Hinderliter PM; Timchalk C; Poet TS
Regul Toxicol Pharmacol; 2011 Oct; 61(1):23-31. PubMed ID: 21651950
[TBL] [Abstract][Full Text] [Related]
17. Monte Carlo analysis of the human chlorpyrifos-oxonase (PON1) polymorphism using a physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model.
Timchalk C; Kousba A; Poet TS
Toxicol Lett; 2002 Sep; 135(1-2):51-9. PubMed ID: 12243863
[TBL] [Abstract][Full Text] [Related]
18. Use of in vitro data in developing a physiologically based pharmacokinetic model: Carbaryl as a case study.
Yoon M; Kedderis GL; Yan GZ; Clewell HJ
Toxicology; 2015 Jun; 332():52-66. PubMed ID: 24863738
[TBL] [Abstract][Full Text] [Related]
19. Cumulative organophosphate pesticide exposure and risk assessment among pregnant women living in an agricultural community: a case study from the CHAMACOS cohort.
Castorina R; Bradman A; McKone TE; Barr DB; Harnly ME; Eskenazi B
Environ Health Perspect; 2003 Oct; 111(13):1640-8. PubMed ID: 14527844
[TBL] [Abstract][Full Text] [Related]
20. Chlorpyrifos PBPK/PD model for multiple routes of exposure.
Poet TS; Timchalk C; Hotchkiss JA; Bartels MJ
Xenobiotica; 2014 Oct; 44(10):868-81. PubMed ID: 24839995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
